Showing results (471-480 of 552) with videos related to
Sort By:
Pageof 56
Journal of the American Academy of Dermatology|August 20, 2021
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trialAndrew Blauvelt, Jonathan I Silverberg, Charles W Lynde, et al.American Journal of Clinical Dermatology|March 26, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)Jonathan I Silverberg, Melinda J Gooderham, Amy S Paller, et al.Dermatitis : Contact, Atopic, Occupational, Drug|July 9, 2021
Contact Allergy in Canada Versus United States: Analysis of the North American Contact Dermatitis Group Data 2005-2016Amber Reck Atwater, Jordan Maxwell Ward, Beiyu Liu, et al.Contact Dermatitis|July 8, 2022
Patch testing with cobalt in children and adolescents: North American contact dermatitis group experience, 2001-2018Jonathan I Silverberg, Nisha Patel, Erin M Warshaw, et al.Journal of the American Academy of Dermatology|February 18, 2021
Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)Eric L Simpson, Seth Forman, Jonathan I Silverberg, et al.Dermatitis : Contact, Atopic, Occupational, Drug|December 4, 2020
Patch Testing of Mercaptobenzothiazole and Mercapto Mix: The North American Contact Dermatitis Group Experience, 1994-2016Erin M Warshaw, Rachit Gupta, Joel G DeKoven, et al.Dermatitis : Contact, Atopic, Occupational, Drug|July 9, 2021
Patch Testing With Tocopherol and Tocopherol Acetate: The North American Contact Dermatitis Group Experience, 2001 to 2016Erin M Warshaw, Jenna L Ruggiero, Joel G DeKoven, et al.Journal of the American Academy of Dermatology|October 11, 2020
Contact dermatitis to personal care products is increasing (but different!) in males and females: North American Contact Dermatitis Group data, 1996-2016Erin M Warshaw, Jamie P Schlarbaum, Jonathan I Silverberg, et al.Dermatology and Therapy|February 14, 2025
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of EfficacyJonathan I Silverberg, Thomas Bieber, Amy S Paller, et al.Dermatitis : Contact, Atopic, Occupational, Drug|July 31, 2023
Patch Testing to Paraphenylenediamine: The North American Contact Dermatitis Group Experience (1994-2018)Erin M Warshaw, Malina Yamashita Peterson, Amber R Atwater, et al.Pageof 56